Personalized model risk assessment
adec2288-e6b0-58d3-b7e2-38dc72f749e5Prediction source Version of record · PDF page(s) 5
Study 2fb72a37-7524-5dc6-a3dd-c6e7f987f374 · Prediction record (JSON)
Prediction fields
- Comparator
- experimental_or_observational_reference · PDF page(s) 5
- Endpoint
- post_infarction_arrhythmia_primary_endpoint__hazard_ratio · PDF page(s) 5
- Family
- clinical_outcomes · PDF page(s) 5
- Measured variable
- post_infarction_arrhythmia_primary_endpoint · PDF page(s) 5
- Measurement role
- clinical_outcome · PDF page(s) 5
- Metric
- hazard_ratio · PDF page(s) 5
- Reference type
- observed_clinical_reference · PDF page(s) 5
- Reported time window
- mean clinical follow-up of 4.8 ± 2.9 years for the signed composite ventricular-arrhythmia endpoint · PDF page(s) 2
- Role
- clinical_outcome · PDF page(s) 5
- Scenario
- retrospective_blinded_outcome_assessment · PDF page(s) 5
Validation Direct comparison · Same source · Sample overlap · Supports · Matched conditions · Statistically significant